• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与费用相关的治疗不依从性方面的种族/民族差异与医疗保险D部分:一项纵向比较

Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison.

作者信息

Bakk Louanne

出版信息

J Health Care Poor Underserved. 2015 Nov;26(4):1132-48. doi: 10.1353/hpu.2015.0113.

DOI:10.1353/hpu.2015.0113
PMID:26548668
Abstract

Little is known about whether racial and ethnic disparities in cost-related medication nonadherence (CRN) have changed since the implementation of Medicare Part D. This longitudinal study examined the impact of Part D on CRN among racial and ethnic minority Medicare beneficiaries, age 65 and older. Nationally representative data were obtained from the Prescription Drug Study and Health and Retirement Study. A differences-in-differences approach was used to compare CRN among non-Hispanic Blacks, Hispanics, and non-Hispanic Whites. The results indicate CRN was higher among the two minority groups than among non-Hispanic Whites before and after Medicare Part D. Mixed-effects logistic regression analyses show that CRN did not significantly change between pre- and post-Medicare Part D for any of these three groups. However, older non-Hispanic Blacks and Hispanics had a larger reduction in CRN than non-Hispanic Whites. These findings suggest that despite Medicare Part D, racial and ethnic disparities in CRN persist.

摘要

自医疗保险D部分实施以来,与费用相关的药物治疗不依从性(CRN)方面的种族和族裔差异是否发生变化,目前所知甚少。这项纵向研究调查了医疗保险D部分对65岁及以上种族和族裔少数医疗保险受益人的CRN的影响。全国代表性数据来自处方药研究和健康与退休研究。采用差异中的差异方法来比较非西班牙裔黑人、西班牙裔和非西班牙裔白人之间的CRN。结果表明,在医疗保险D部分实施之前和之后,两个少数群体中的CRN均高于非西班牙裔白人。混合效应逻辑回归分析表明,这三组人群在医疗保险D部分实施前后,CRN均无显著变化。然而,年龄较大的非西班牙裔黑人和西班牙裔在CRN方面的降幅比非西班牙裔白人更大。这些发现表明,尽管有医疗保险D部分,但CRN方面的种族和族裔差异依然存在。

相似文献

1
Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison.与费用相关的治疗不依从性方面的种族/民族差异与医疗保险D部分:一项纵向比较
J Health Care Poor Underserved. 2015 Nov;26(4):1132-48. doi: 10.1353/hpu.2015.0113.
2
Medicare Part D coverage gap: race, gender, and cost-related medication nonadherence.医疗保险D部分覆盖缺口:种族、性别与费用相关的药物治疗不依从性
Soc Work Public Health. 2015;30(6):473-85. doi: 10.1080/19371918.2015.1052607. Epub 2015 Aug 6.
3
Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.癌症幸存者中与费用相关的药物不依从的种族和民族差异。
J Cancer Surviv. 2016 Jun;10(3):534-44. doi: 10.1007/s11764-015-0499-y. Epub 2015 Nov 30.
4
Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.基于星级评定与《医疗保险现代化法案》相比,在符合 MTM 资格标准方面的种族和民族差异。
J Manag Care Spec Pharm. 2018 Feb;24(2):97-107. doi: 10.18553/jmcp.2018.24.2.97.
5
Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.医疗保险D部分补贴与激素治疗持续性和依从性方面的种族差异。
J Clin Oncol. 2016 Dec 20;34(36):4398-4404. doi: 10.1200/JCO.2016.67.3350. Epub 2016 Oct 24.
6
Did Medicare Part D reduce disparities?医疗保险D部分是否减少了差异?
Am J Manag Care. 2015 Feb;21(2):119-28.
7
Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare.医疗保险中新型丙型肝炎药物使用的种族-民族差异。
J Racial Ethn Health Disparities. 2017 Dec;4(6):1147-1158. doi: 10.1007/s40615-016-0320-2. Epub 2016 Dec 7.
8
Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.非老年人口在满足 Part D MTM 资格标准方面的种族和民族差异。
J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e87-96. doi: 10.1331/JAPhA.2012.11146.
9
Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.非医疗保险人群在满足医疗保险药物治疗管理资格方面的种族和族裔差异的历史趋势。
Res Social Adm Pharm. 2014 Nov-Dec;10(6):904-917. doi: 10.1016/j.sapharm.2014.02.007. Epub 2014 Mar 2.
10
Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?医疗保险部分 D 是否减少了处方药使用和支出方面的种族/民族差异?
Health Serv Res. 2014 Apr;49(2):502-25. doi: 10.1111/1475-6773.12099. Epub 2013 Sep 18.

引用本文的文献

1
What role does wealth play in the racial health gap in the United States? Examining differences among African Americans, Latinos, and non-Hispanic Whites.财富在美国种族健康差距中扮演着什么角色?研究非裔美国人、拉丁裔和非西班牙裔白人之间的差异。
SSM Popul Health. 2025 Jan 9;29:101752. doi: 10.1016/j.ssmph.2025.101752. eCollection 2025 Mar.
2
Factors associated with fall risk increasing drug use in older black and white men and women: the Health ABC Study.与老年黑人和白人男性及女性跌倒风险增加相关的药物使用因素:健康老龄化研究。
BMC Geriatr. 2024 Sep 19;24(1):773. doi: 10.1186/s12877-024-05301-w.
3
Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance program.
成本相关的处方不依从与系统性红斑狼疮患者报告结局:密歇根狼疮流行病学和监测计划。
Lupus. 2023 Aug;32(9):1075-1083. doi: 10.1177/09612033231186113. Epub 2023 Jun 28.
4
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
5
Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities.低收入黑人和西班牙裔城市社区中处方药的药房可及性及与费用相关的使用不足情况。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2):162-169.e1. doi: 10.1016/j.japh.2016.12.065. Epub 2017 Jan 30.
6
Impact of Medicare Part D on Racial and Ethnic Minorities.医疗保险处方药福利计划(Medicare Part D)对少数族裔的影响。
Divers Equal Health Care. 2016;13(5):326-333. Epub 2016 Aug 23.
7
Patient-reported financial barriers to adherence to treatment in neurology.患者报告的神经科治疗依从性的经济障碍。
Clinicoecon Outcomes Res. 2016 Nov 17;8:685-694. doi: 10.2147/CEOR.S119971. eCollection 2016.